Market capitalization | HKD5.18b |
Enterprise Value | HKD5.86b |
P/E (TTM) P/E ratio | 8.27 |
EV/FCF (TTM) EV/FCF | 7.60 |
EV/Sales (TTM) EV/Sales | 0.54 |
P/S ratio (TTM) P/S ratio | 0.48 |
P/B ratio (TTM) P/B ratio | 0.77 |
Dividend yield | 3.55% |
Last dividend (FY24) | HKD0.14 |
As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.
4 Analysts have issued a China Resources Medical forecast:
4 Analysts have issued a China Resources Medical forecast:
Dec '24 |
+/-
%
|
||
Revenue | 10,753 10,753 |
3%
3%
|
|
Gross Profit | 1,975 1,975 |
5%
5%
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 940 940 |
15%
15%
|
Net Profit | 617 617 |
120%
120%
|
In millions HKD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
China Resources Medical Holdings Co., Ltd. is an investment holding company, which engages in the provision of hospital management services. The company is headquartered in Beijing, Beijing and currently employs 19,953 full-time employees. The company went IPO on 2013-11-29. The firm is engaged in providing comprehensive medical services, providing hospital management services, and selling medicines, medical devices and medical consumables, as well as providing other hospital derivative services to related hospitals. The firm operates in two segments. Hospital Business segment includes outpatient and inpatient services corresponding to its own hospitals. Other Business segment includes operation management services, supply chain services and other derivative services provided to joint-stock hospitals and IOT/OT hospitals. The firm mainly operates in the domestic market.
Head office | China |
Employees | 19,953 |
Website | www.crmedical.hk |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.